ASEAN Infusion Pump Market: Growth, Size, Share, and Trends

Report Code MD 8084
Published in Jul, 2025, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

ASEAN Infusion Pump Market by Product (Accessories (Dedicated (Volumetric Pumps, Insulin Pumps, Enteral Pumps) & Non-dedicated), Devices (Traditional, Specialty)), Application (Oncology, Diabetes, Pain Management), End User - Global Forecast to 2030

Overview

The global ASEAN infusion pump market, valued at US$1.18 billion in 2024, stood at US$1.26 billion in 2025 and is projected to advance at a resilient CAGR of 7.1% from 2025 to 2030, culminating in a forecasted valuation of US$1.78 billion by the end of the period. The ASEAN infusion pump market is experiencing significant growth, driven by heightened healthcare awareness and enhanced access to sophisticated medical technologies throughout the region. Increased capital investments in healthcare infrastructure, particularly in rural and underserved populations, are facilitating the broader adoption of infusion pumps. Furthermore, the rising demand for minimally invasive treatment modalities, alongside the escalating prevalence of infectious diseases necessitating intravenous therapies, are pivotal factors propelling market expansion. The growth of home healthcare services and the movement towards personalized medicine are also instrumental in shaping the dynamics of this market.

ASEAN Infusion Pump Market – Global Forecast and Key Opportunities to 2030

Attractive Opportunities in the ASEAN Infusion Pump Market

ASEAN

The growth of Thailand's infusion pump market is propelled by the rising prevalence of chronic diseases, particularly cancer and diabetes, which necessitate precise and continuous medication delivery. Thailand's universal healthcare system, covering over 99% of its population, ensures widespread access to medical treatments, further supporting market expansion. Technological advancements, such as the development of smart and portable infusion pumps, enhance patient care and safety, making them more attractive to healthcare providers.

The growth of the South Korean infusion pump market is propelled by several key factors. Foremost is the rising prevalence of diabetes, particularly Type 1, which necessitates continuous and precise insulin delivery systems such as infusion pumps; this demand is further supported by government initiatives, including reimbursement policies under the National Health Insurance program, enhancing accessibility to advanced diabetes management devices.

The infusion pump market in Singapore is expanding due to several interrelated factors. The country's aging population and increasing prevalence of chronic diseases, such as diabetes and cardiovascular diseases, drive the demand for precise and continuous medication delivery.

The ASEAN infusion pump market is expected to be worth USD 1.78 billion by 2030, growing at a CAGR of 7.1% during the forecast period.

The Indonesian infusion pump market is experiencing significant growth driven by several key factors. The increasing prevalence of chronic diseases such as diabetes and cancer has led to a higher demand for precise and reliable medication delivery systems.

Global ASEAN Infusion Pump Market Dynamics

DRIVER: Rising demand for ambulatory infusion pumps in homecare settings

The ASEAN infusion pump market is experiencing substantial growth, primarily driven by the surging demand for ambulatory infusion pumps in home care settings. This increase is largely attributed to a significant shift in patient and healthcare provider preferences for more convenient and continuous drug delivery methods that extend beyond traditional hospital environments. A critical factor contributing to this trend is the rising prevalence of chronic diseases, such as diabetes, cancer, and cardiovascular disorders. These conditions often necessitate long-term management and precise medication administration, thereby enhancing the necessity for reliable infusion technologies that can provide sustained treatment over extended periods. Ambulatory infusion pumps, in particular, have gained traction due to their improved mobility features and user-friendly interfaces. These devices empower patients to manage their treatments independently, allowing them greater freedom to engage in daily activities while ensuring they receive the required therapies at scheduled intervals. The convenience offered by these pumps is increasingly appealing to both patients and healthcare providers who are aiming for more adaptable and patient-centric treatment options. Moreover, advancements in infusion pump technology have contributed to their growing popularity. Innovations such as miniaturization, wireless connectivity, and enhanced safety features have not only improved the functionality of these devices but also boosted confidence in their use among patients and medical professionals alike. Additionally, the expansion of home healthcare infrastructure across the ASEAN region is pivotal in supporting this market growth. As healthcare systems evolve to meet the needs of aging populations and increasing chronic disease prevalence, the integration of homecare solutions becomes crucial. This infrastructure development provides an essential backdrop for the adoption of ambulatory infusion pumps, making them more accessible to a broader range of patients who are seeking effective management of their health conditions. In summary, the combined impact of rising chronic disease cases, patient-driven preferences for mobility and ease of use, technological advancements in infusion systems, and bolstered home healthcare networks are collectively propelling the infusion pump market forward within the ASEAN region.

RESTRAINT: Increasing number of product recalls

Product recalls within the ASEAN infusion pump market present considerable challenges that serve as significant impediments to its growth. Such recalls typically arise from a range of safety concerns, including device malfunctions, software errors, and inaccuracies in drug delivery mechanisms. These issues not only have the potential to cause serious harm to patients but also significantly undermine the credibility of the infusion pump technology among healthcare providers and patients alike. As trust diminishes, healthcare providers become increasingly hesitant to adopt new infusion pump technologies, which leads to a more cautious approach toward implementing these critical medical devices. This cautious adoption is exacerbated by heightened regulatory scrutiny as regulatory bodies intensify their oversight in response to safety concerns. Such scrutiny can create a more complex and challenging environment for manufacturers as they navigate the intricate regulatory landscape across various ASEAN countries, each with its unique compliance requirements. Moreover, product recalls bring substantial financial repercussions for manufacturers, leading to direct losses associated with the recall process, as well as indirect losses tied to diminished sales due to increased consumer wariness. Additionally, these incidents can significantly delay the introduction of new products into the market, stifling innovation and limiting the overall availability of advanced infusion pump solutions. The intricate nature of regulatory compliance across the diverse nations within the ASEAN region further complicates the situation, as manufacturers must adapt to different regulations and standards, which can lead to higher risks and frequency of recalls. Ultimately, this multifaceted challenge not only restricts market expansion but also dims investor confidence, making it increasingly difficult for companies to secure the necessary funding for R&D in this critical healthcare sector.

 

OPPORTUNITY: High growth opportunities in emerging markets

Emerging countries within the ASEAN region, particularly Indonesia, Vietnam, and the Philippines, present a wealth of growth opportunities for the infusion pump market. This potential stems from their rapidly expanding healthcare infrastructure and a marked increase in government initiatives aimed at enhancing medical facilities. Over recent years, these nations have experienced a consistent rise in healthcare spending, driven by both public and private investments, as well as a burgeoning middle class that increasingly demands higher-quality medical care. This shift is significantly contributing to the adoption of advanced medical technologies, including infusion pumps, which are essential for delivering accurate and efficient patient treatment. Moreover, the challenges posed by limited access to healthcare services in rural areas indicate a substantial market for portable and user-friendly infusion technologies, particularly suited for home care environments. The growing prevalence of chronic diseases, such as diabetes and hypertension, alongside infectious conditions, is placing additional pressure on healthcare systems in these countries. This escalating healthcare need not only necessitates the use of modern medical devices like infusion pumps but also makes these markets particularly attractive for manufacturers seeking to expand their regional presence. The combination of an expanding healthcare infrastructure, increased healthcare spending, a demand for quality care, and the urgent need to address both chronic and infectious diseases positions the ASEAN region as a dynamic and promising market for infusion pump manufacturers looking to capitalize on these emerging opportunities.

CHALLENGES: Increasing incidence of medication errors and lack of wireless connectivity in majority of hospitals

The ASEAN infusion pump market is currently grappling with several significant challenges that have a profound impact on patient safety and the overall adoption of advanced medical technologies. One of the most pressing issues is the rising incidence of medication errors, which can have serious consequences for patient health and outcomes. These errors not only elevate concerns among healthcare providers and patients alike but also hinder the broader acceptance and integration of infusion pump systems designed to enhance safety and efficiency within clinical environments. In addition to medication errors, many hospitals across the ASEAN region continue to operate without the necessary advanced wireless connectivity and integration capabilities that are crucial for the effective functioning of smart infusion pumps. These devices are designed to leverage real-time data exchange, allowing for precise drug delivery and continuous monitoring of patient responses. However, the existing technological gap in many healthcare facilities restricts the implementation of fully automated systems that can significantly reduce the potential for errors and improve patient care outcomes. Compounding these challenges is the widespread lack of adequate training and awareness among healthcare professionals regarding the capabilities and benefits of modern infusion pump technologies. This gap in understanding not only limits the optimal utilization of these devices but also creates substantial barriers to their acceptance within clinical settings. As healthcare providers may be hesitant to adopt new technologies without proper training and knowledge, the market faces a slowdown in growth and innovation. Addressing these challenges will be critical for advancing the infusion pump market in the ASEAN region and enhancing overall patient safety.

Global ASEAN Infusion Pump Market Ecosystem Analysis

ASEAN Infusion Pump Market Ecosystem
 

By product, the accessories and consumables segment is expected to register the highest CAGR during the forecast period.

Based on products, the ASEAN infusion pump market has been segmented into accessories & consumables and devices. The forecast period anticipates substantial growth within the accessories & consumables segment, outpacing other market sectors. The expansion of the infusion pump market is largely fueled by the widespread adoption of these sophisticated medical devices, which are essential for the precise and regulated administration of medications. Infusion pumps are particularly crucial in acute care settings, such as hospitals and outpatient clinics, where they significantly enhance the quality and safety of patient care. As healthcare providers increasingly rely on these devices for a wide range of treatments, the demand for infusion pumps continues to rise. This trend is further amplified by the regular need for replacement and replenishment of various accessories and consumables associated with the pumps. These components are vital for their optimal functioning and help ensure that treatments are administered safely and effectively. As medical professionals strive to improve patient outcomes and streamline treatment protocols, the market for supporting accessories and consumables is on the verge of substantial growth. This reflects a broader movement within the healthcare industry towards maximizing efficiency and efficacy, ultimately leading to better care for patients and more successful treatment experiences.

By end users, hospitals are expected to be the largest market segment during the forecast period.

Hospitals are progressively integrating ASEAN infusion pump systems into their operations, driven by a variety of significant factors that not only improve patient care but also enhance overall operational efficiency. One of the primary motivations for this shift is the alarming increase in healthcare-associated infections (HAIs), which pose a serious threat to patient safety. As these infections become more prevalent, the necessity for strict environmental controls in critical areas such as isolation units and operating rooms has never been more pressing. ASEAN infusion pump systems are instrumental in achieving these stringent environmental standards. These advanced systems are specifically designed to regulate and maintain precise pressure differentials within clinical settings. By doing so, they play a vital role in preventing the potential transfer of pathogens between patients, which is essential for minimizing the risk of infection. Furthermore, the implementation of these infusion pumps not only assists in maintaining a sterile environment but also enhances operational workflows. By automating the delivery of medications and fluids, they reduce the workload on healthcare personnel, allowing them to focus more on direct patient care. Overall, the use of ASEAN infusion pump systems is a critical advancement in the fight against HAIs, prioritizing patient health and safety while also streamlining hospital operations.

South Korea held the largest share of the ASEAN infusion pump market in 2024

The infusion pump market within the ASEAN region is currently witnessing substantial growth, driven by a confluence of critical factors that are reshaping the healthcare landscape. In South Korea specifically, this market growth is particularly pronounced, attributed to a variety of influences. One of the primary factors contributing to this expansion is the increasing prevalence of chronic diseases, notably diabetes. As the number of individuals diagnosed with these conditions rises, there is a corresponding demand for precise and continuous drug delivery systems that infusion pumps provide. These devices are essential for managing complicated treatment regimens, which require careful monitoring and administration of medications. Moreover, the landscape of infusion technology is evolving thanks to significant technological advancements. The integration of artificial intelligence (AI) and the Internet of Things (IoT) into infusion pumps has led to improved functionality and efficiency. These smart infusion systems offer features like real-time monitoring, data analytics, and enhanced safety measures, which contribute to better patient outcomes and streamline the administration process for healthcare providers. In addition to technological innovations, government initiatives have played a pivotal role in fostering market growth. Support for R&D, alongside favorable healthcare policies, has created an environment conducive to innovation and investment in advanced medical technologies. Such initiatives often aim to enhance healthcare services and ensure better access to effective treatment options. Furthermore, the growing aging population is a significant factor driving the demand for advanced medical devices, including infusion pumps. As more individuals enter their senior years, the likelihood of developing chronic health issues increases, leading to an escalated need for advanced drug delivery systems that can cater to their intricate healthcare needs. In summary, the combination of rising chronic disease prevalence, advancements in technology, supportive government policies, and an aging demographic all contribute to a promising outlook for the infusion pump market in South Korea. This dynamic market environment indicates a robust future for infusion pump technologies, which are poised to transform patient care in the region.

SOUTH KOREA WILL REGISTER THE HIGHEST CAGR DURING THE STUDY PERIOD.
SOUTH KOREA IS THE FASTEST-GROWING MARKET IN THE REGION
ASEAN Infusion Pump Market Region

Recent Developments of ASEAN Infusion Pump Market

  • In April 2025, the US FDA cleared the BD Alaris Infusion System with Guardrails Suite MX (including modules like PC Unit, Pump, Syringe, PCA, EtCO2, Auto-ID, and System Manager) as safe and effective for market use. This clearance, granted on April 25, 2025, confirms the system is substantially equivalent to previously approved devices and can now be legally sold in the US.
  • In July 2025, BD announced that the updated BD Alaris Infusion System received 510(k) clearance from the US Food and Drug Administration (FDA); this enables both remediation and a return to full commercial operations for the most comprehensive infusion system available in the US.
  • In September 2024, B. Braun Medical Inc. (B. Braun) received US Food and Drug Administration (FDA) 510(k) clearance for the Introcan Safety 2 Deep Access IV Catheter, the newest addition to the Introcan Safety 2 IV Catheter portfolio.
  • In December 2024, Baxter signed a definitive agreement to divest its BioPharma Solutions (“BPS”) business to Advent International (“Advent”) and Warburg Pincus. Under the terms of the definitive agreement, BPS has been a leading provider of sterile contract manufacturing solutions, parenteral delivery systems, and customized support services to the pharma and biotech industries for decades.

Key Market Players

KEY PLAYERS IN THE ASEAN INFUSION PUMP MARKET INCLUDE

Scope of the Report

Report Metric Details
Market size available for years 2023-2032
Base Year Considered 2024
Forecast period 2025-2032
Forecast units Value (USD Million/Billion)
Segments covered By product, application, and end user
Geographies covered Philippines, Malaysia, Singapore, Thailand, Indonesia, Vietnam, South Korea

Frequently Asked Questions (FAQ)

What is the expected addressable market value of the ASEAN infusion pump market over the next five years?

The ASEAN infusion pump market is projected to reach USD 1.78 billion by 2030 from USD 1.26 billion in 2025, at a CAGR of 7.1% from 2025 to 2030.

What are the key drivers for the ASEAN infusion pump market?

The ASEAN infusion pump market is witnessing robust growth driven by critical factors, including the rising incidence of chronic diseases and significant technological advancements. Additionally, the integration of infusion pumps with digital health platforms is enhancing their functionality and appeal in clinical settings.

Which segments have been included in this report?

The report includes: By Product – Accessories & Consumables: Dedicated and Non-dedicated accessories By Product – Devices: Volumetric, Insulin, Enteral, Syringe, Ambulatory, PCA, Implantable infusion pumps By Technology: Traditional and Specialty infusion pumps By Type: Stationary and Portable infusion pumps By Application: Chemotherapy/Oncology, Diabetes Management, Gastroenterology, Pain Management/Analgesia, Pediatrics/Neonatology, Hematology, Other Applications By End User: Hospitals, Homecare Settings, Ambulatory Care Settings, Academic & Research Institutes By Country: Philippines, Malaysia, Singapore, Thailand, Indonesia, Vietnam, South Korea

Which are the top industry players in the ASEAN infusion pump market?

Major players include Becton, Dickinson and Company (US), B. Braun Melsungen AG (Germany), Fresenius Kabi AG (Germany), Baxter (US), Medtronic (Ireland), ICU Medical, Inc. (US), Avanos Medical, Inc. (US), Terumo Corporation (Japan), Nipro Corporation (Japan), JMS Co., Ltd. (Japan), Cardinal Health (US), Epic Medical (Singapore), F. Hoffmann-La Roche Ltd. (Switzerland), Abbott Laboratories (US), and Danaher (US).

Which country is dominating the ASEAN infusion pump market?

South Korea is dominating the ASEAN infusion pump market. Key factors include growing investment in healthcare infrastructure, high prevalence of chronic diseases, and a rising geriatric population.

Which is the leading infusion pump type segment in the ASEAN infusion pump devices market?

The stationary infusion pumps segment held the largest share in 2024, driven by their wide range of applications, lower cost compared to portable pumps, and high hospital adoption rates.

Adjacent Markets

Request Bundle Reports

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the ASEAN Infusion Pump Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
27
RESEARCH METHODOLOGY
32
EXECUTIVE SUMMARY
46
PREMIUM INSIGHTS
50
MARKET OVERVIEW
54
  • 5.1 MARKET DYNAMICS
    MARKET DRIVERS
    - Rising demand for ambulatory infusion pumps in home care settings
    - Rapid growth in geriatric population and subsequent rise in chronic diseases
    - Increased adoption of enteral feeding pumps due to surge in pre-term births
    - Growing number of surgical procedures performed worldwide
    - Increased safety & cybersecurity requirements
    RESTRAINTS
    - Product recalls
    - Stringent regulatory requirements for new product approvals
    - Increasing adoption of refurbished & rented infusion pumps
    OPPORTUNITIES
    - High growth of emerging economies
    - Growing popularity of specialty infusion systems
    CHALLENGES
    - Increasing incidence of medication errors and inadequate wireless connectivity in most hospitals
  • 5.2 INDUSTRY TRENDS
    SMART PUMP-EMR INTEROPERABILITY
    DEVELOPMENT OF HYBRID CLOSED-LOOP SYSTEMS/ARTIFICIAL PANCREAS DEVICE SYSTEMS
    GROWING DEMAND FOR SPECIALTY PUMPS WITH ADVANCED FEATURES
  • 5.3 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGIES
    - Flow generation
    - Smart infusion systems
    - Closed-loop infusion control
    COMPLEMENTARY TECHNOLOGIES
    - Dose error reduction systems
    - Wireless connectivity
    - AI-powered decision support systems
    ADJACENT TECHNOLOGIES
    - Embedded software
    - Sensing technology
  • 5.4 PORTER’S FIVE FORCES ANALYSIS
    THREAT OF NEW ENTRANTS
    THREAT OF SUBSTITUTES
    BARGAINING POWER OF SUPPLIERS
    BARGAINING POWER OF BUYERS
    INTENSITY OF COMPETITIVE RIVALRY
  • 5.5 KEY STAKEHOLDERS AND BUYING CRITERIA
    KEY STAKEHOLDERS IN BUYING PROCESS
    BUYING CRITERIA
  • 5.6 REGULATORY LANDSCAPE
    REGULATORY ANALYSIS
    - Philippines
    - Malaysia
    - Vietnam
    - Singapore
    - Indonesia
    - Thailand
    - South Korea
    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.7 PATENT ANALYSIS
    PATENT PUBLICATION TRENDS FOR INFUSION PUMPS
    INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
  • 5.8 TRADE ANALYSIS
    EXPORT DATA FOR HS CODE 901890
    IMPORT DATA FOR HS CODE 901890
  • 5.9 PRICING ANALYSIS
    AVERAGE SELLING PRICE, BY KEY PLAYER
    AVERAGE SELLING PRICE, BY REGION
  • 5.10 KEY CONFERENCES AND EVENTS, 2025–2026
  • 5.11 UNMET NEEDS/END-USER EXPECTATIONS
  • 5.12 IMPACT OF AI ON ASEAN INFUSION PUMPS MARKET
    INTRODUCTION
    MARKET POTENTIAL IN ASEAN INFUSION PUMPS ECOSYSTEM
    AI USE CASES
    KEY COMPANIES IMPLEMENTING AI IN INFUSION PUMPS
    FUTURE OF GEN AI IN ASEAN INFUSION PUMPS ECOSYSTEM
  • 5.13 ECOSYSTEM ANALYSIS
  • 5.14 CASE STUDY ANALYSIS
  • 5.15 VALUE CHAIN ANALYSIS
  • 5.16 ADJACENT MARKET ANALYSIS
  • 5.17 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • 5.18 INVESTMENT AND FUNDING SCENARIO
  • 5.19 IMPACT OF 2025 US TARIFF – ASEAN INFUSION PUMPS MARKET
    INTRODUCTION
    KEY TARIFF RATES
    PRICE IMPACT ANALYSIS
    IMPACT ON COUNTRY
    IMPACT ON END-USE INDUSTRIES
ASEAN INFUSION PUMPS MARKET, BY PRODUCT
99
  • 6.1 INTRODUCTION
  • 6.2 ACCESSORIES AND CONSUMABLES
    DEDICATED ACCESSORIES AND CONSUMABLES
    - Volumetric infusion pumps
    - Insulin infusion pumps
    - Enteral infusion pumps
    - Syringe infusion pumps
    - Ambulatory infusion pumps
    - PCA pumps
    - Implantable infusion pumps
    NON-DEDICATED ACCESSORIES AND CONSUMABLES
    - Infusion catheters
    - IV/Administration sets
    - Needleless connectors
    - Cannulas
    - Tubing and extension sets
    - Valves
    - Other non-dedicated accessories and consumables
  • 6.3 DEVICES
    DEVICES MARKET, BY TYPE
    - Volumetric infusion pumps
    - Insulin infusion pumps
    - Ambulatory infusion pumps
    - Syringe infusion pumps
    - Enteral infusion pumps
    - PCA pumps
    - Implantable infusion pumps
    DEVICES MARKET, BY TECHNOLOGY
    - Traditional infusion pumps
    - Specialty infusion pumps
    DEVICES MARKET, BY TYPE
    - Stationary infusion pumps
    - Portable infusion pumps
ASEAN INFUSION PUMPS MARKET, BY APPLICATION
150
  • 7.1 INTRODUCTION
  • 7.2 CHEMOTHERAPY/ONCOLOGY
    GROWING INCIDENCE OF CANCER TO DRIVE DEMAND
  • 7.3 DIABETES MANAGEMENT
    INCREASED DEMAND FOR EFFECTIVE DIABETES TREATMENT TO BOOST MARKET
  • 7.4 GASTROENTEROLOGY
    GROWING USE IN GASTROINTESTINAL DISEASE TREATMENT TO DRIVE DEMAND
  • 7.5 ANALGESIA/PAIN MANAGEMENT
    RISING NUMBER OF SURGICAL PROCEDURES TO PROPEL DEMAND
  • 7.6 PEDIATRICS/NEONATOLOGY
    GROWING INCIDENCE OF PEDIATRIC DIABETES TO DRIVE MARKET
  • 7.7 HEMATOLOGY
    INCREASING PREVALENCE OF BLOOD DISORDERS TO SUPPORT MARKET GROWTH
  • 7.8 OTHER APPLICATIONS
ASEAN INFUSION PUMPS MARKET, BY END USER
165
  • 8.1 INTRODUCTION
  • 8.2 HOSPITALS
    STRONG FINANCIAL CAPABILITIES, HIGH NUMBER OF REGULAR AND ICU BEDS, LARGE PATIENT POOL TO DRIVE MARKET
  • 8.3 HOME CARE SETTINGS
    GROWING BURDEN OF NON-COMMUNICABLE DISEASES TO DRIVE DEMAND
  • 8.4 AMBULATORY CARE SETTINGS
    RISING NUMBER OF SURGICAL PROCEDURES TO BOOST MARKET
  • 8.5 ACADEMIC AND RESEARCH INSTITUTES
    RISING MEDICAL RESEARCH ACTIVITIES TO SUPPORT MARKET GROWTH
ASEAN INFUSION PUMPS MARKET, BY COUNTRY
173
  • 9.1 INTRODUCTION
    MACROECONOMIC OUTLOOK FOR ASEAN COUNTRIES
    PHILIPPINES
    - Government investment and public hospital modernization to fuel demand
    MALAYSIA
    - Rising healthcare investment and technological advancements to drive market
    VIETNAM
    - Growing aging population and healthcare infrastructure development to fuel market
    SINGAPORE
    - Advanced healthcare infrastructure and technological integration to boost market
    INDONESIA
    - Rising prevalence of chronic diseases to drive market
    THAILAND
    - Rising geriatric population and chronic diseases to drive market
    SOUTH KOREA
    - Expanding technological base and healthcare infrastructure to drive market
COMPETITIVE LANDSCAPE
218
  • 10.1 OVERVIEW
  • 10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2022–2025
  • 10.3 REVENUE ANALYSIS, 2020–2024
  • 10.4 MARKET SHARE ANALYSIS, 2024
  • 10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT: KEY PLAYERS, 2024
    - Company footprint
    - Product footprint
    - Application footprint
    - End user footprint
  • 10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
    PROGRESSIVE COMPANIES
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
    - Detailed list of key startups/SMEs
    - Competitive benchmarking of key startups/SMEs
  • 10.7 R&D EXPENDITURE OF KEY PLAYERS
  • 10.8 COMPANY VALUATION AND FINANCIAL METRICS
    COMPANY VALUATION
    FINANCIAL METRICS
  • 10.9 BRAND/PRODUCT COMPARISON
  • 10.10 COMPETITIVE SCENARIO
    PRODUCT LAUNCHES & APPROVALS
    DEALS
    EXPANSIONS
    OTHER DEVELOPMENTS
COMPANY PROFILES
244
  • 11.1 KEY PLAYERS
    BECTON, DICKINSON AND COMPANY
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    B. BRAUN MELSUNGEN AG
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    BAXTER INTERNATIONAL INC.
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    FRESENIUS KABI
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    MEDTRONIC PLC
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    TERUMO CORPORATION
    - Business overview
    - Products offered
    - Recent developments
    ICU MEDICAL, INC.
    - Business overview
    - Products offered
    - Recent developments
    AVANOS MEDICAL, INC.
    - Business overview
    - Products offered
    NIPRO CORPORATION
    - Business overview
    - Products offered
    - Recent developments
    JMS CO., LTD.
    - Business overview
    - Products offered
    CARDINAL HEALTH, INC.
    - Business overview
    - Products offered
    ROCHE DIAGNOSTICS
    - Business overview
    - Products offered
    - Recent developments
    ABBOTT LABORATORIES
    - Business overview
    - Products offered
    DANAHER CORPORATION
    - Business overview
    - Products offered
    YPSOMED HOLDING AG
    - Business overview
    - Products offered
  • 11.2 OTHER PLAYERS
    SOOIL DEVELOPMENTS CO., LTD.
    EPIC MEDICAL
    MINDRAY MEDICAL INTERNATIONAL LIMITED
    BIONET CO., LTD.
    TANDEM DIABETES CARE, INC.
    SHENZHEN MEDRENA BIOTECH CO., LTD.
    ALLIED MEDICAL LIMITED
    BPL MEDICAL TECHNOLOGIES
    NAREENA LIFESCIENCES PRIVATE LIMITED
    HARVARD BIOSCIENCE INC.
APPENDIX
318
  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 12.3 CUSTOMIZATION OPTIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 1 STANDARD CURRENCY CONVERSION RATES (UNIT OF USD)
  • TABLE 2 RECENT DEVELOPMENTS IN SMART PUMP-EMR INTEROPERABILITY
  • TABLE 3 HYBRID CLOSED-LOOP SYSTEMS: CURRENT MARKET SCENARIO
  • TABLE 4 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS
  • TABLE 5 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS
  • TABLE 6 ASEAN COUNTRIES: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 7 ASEAN INFUSION PUMPS MARKET: MAJOR PATENTS
  • TABLE 8 EXPORT DATA FOR HS CODE 901890 (INCLUDING INFUSION PUMPS), BY COUNTRY, 2021–2024 (USD THOUSAND)
  • TABLE 9 IMPORT DATA FOR HS CODE 901890 (INCLUDING INFUSION PUMPS), BY COUNTRY, 2021–2024 (USD THOUSAND)
  • TABLE 10 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY DEVICE, 2022–2024
  • TABLE 11 AVERAGE SELLING PRICE TREND OF INFUSION PUMP DEVICES IN ASEAN COUNTRIES, 2022–2024
  • TABLE 12 ASEAN INFUSION PUMPS MARKET: KEY CONFERENCES AND EVENTS, 2025–2026
  • TABLE 13 KEY COMPANIES IMPLEMENTING AI IN INFUSION PUMPS
  • TABLE 14 ASEAN INFUSION PUMP PROVIDERS: ROLE OF COMPANIES IN ECOSYSTEM
  • TABLE 15 CASE STUDY 1: PORTABLE AMBULATORY INFUSIONPUMP PROGRAM IN INDONESIA
  • TABLE 16 CASE STUDY 2: SMART VOLUMETRIC INFUSION PUMP PILOT IN THAILAND
  • TABLE 17 CASE STUDY 3: LOCALIZED SYRINGE PUMP INNOVATION IN VIETNAM
  • TABLE 18 US ADJUSTED RECIPROCAL TARIFF RATES
  • TABLE 19 KEY PRODUCT-RELATED TARIFF EFFECTIVE (%) FOR ASEAN INFUSION PUMPS
  • TABLE 20 ASEAN COUNTRIES: IMPACT DUE TO US TARIFFS
  • TABLE 21 ASEAN INFUSION PUMPS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 22 KEY PLAYERS PROVIDING INFUSION PUMP ACCESSORIES AND CONSUMABLES
  • TABLE 23 ACCESSORIES AND CONSUMABLES: ASEAN INFUSION PUMPS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 24 ACCESSORIES AND CONSUMABLES: ASEAN INFUSION PUMPS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 25 KEY PLAYERS PROVIDING DEDICATED ACCESSORIES AND CONSUMABLES
  • TABLE 26 ASEAN DEDICATED ACCESSORIES AND CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 27 ASEAN DEDICATED ACCESSORIES AND CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 28 KEY PLAYERS PROVIDING VOLUMETRIC INFUSION PUMPS (DEDICATED ACCESSORIES)
  • TABLE 29 ASEAN DEDICATED ACCESSORIES AND CONSUMABLES MARKET FOR VOLUMETRIC INFUSION PUMPS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 30 KEY PLAYERS PROVIDING INSULIN INFUSION PUMPS
  • TABLE 31 ASEAN DEDICATED ACCESSORIES AND CONSUMABLES MARKET FOR INSULIN INFUSION PUMPS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 32 KEY PLAYERS PROVIDING ENTERAL INFUSION PUMPS (DEDICATED ACCESSORIES)
  • TABLE 33 ASEAN DEDICATED ACCESSORIES AND CONSUMABLES MARKET FOR ENTERAL INFUSION PUMPS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 34 KEY PLAYERS PROVIDING SYRINGE INFUSION PUMPS (DEDICATED ACCESSORIES)
  • TABLE 35 ASEAN DEDICATED ACCESSORIES AND CONSUMABLES MARKET FOR SYRINGE INFUSION PUMPS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 36 KEY PLAYERS PROVIDING AMBULATORY INFUSION PUMPS (DEDICATED ACCESSORIES)
  • TABLE 37 ASEAN DEDICATED ACCESSORIES AND CONSUMABLES MARKET FOR AMBULATORY INFUSION PUMPS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 38 KEY PLAYERS PROVIDING PCA PUMPS
  • TABLE 39 ASEAN DEDICATED ACCESSORIES AND CONSUMABLES MARKET FOR PCA PUMPS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 40 KEY PLAYERS PROVIDING IMPLANTABLE INFUSION PUMPS (DEDICATED ACCESSORIES)
  • TABLE 41 ASEAN DEDICATED ACCESSORIES AND CONSUMABLES MARKET FOR IMPLANTABLE INFUSION PUMPS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 42 KEY PLAYERS PROVIDING NON-DEDICATED ACCESSORIES AND CONSUMABLES
  • TABLE 43 ASEAN NON-DEDICATED ACCESSORIES AND CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 44 ASEAN NON-DEDICATED ACCESSORIES AND CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 45 KEY PLAYERS PROVIDING INFUSION CATHETERS
  • TABLE 46 ASEAN NON-DEDICATED ACCESSORIES AND CONSUMABLES MARKET FOR INFUSION CATHETERS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 47 KEY PLAYERS PROVIDING IV/ADMINISTRATION SETS
  • TABLE 48 ASEAN NON-DEDICATED ACCESSORIES AND CONSUMABLES MARKET FOR IV/ADMINISTRATION SETS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 49 KEY PLAYERS PROVIDING NEEDLELESS CONNECTORS
  • TABLE 50 ASEAN NON-DEDICATED ACCESSORIES AND CONSUMABLES MARKET FOR NEEDLELESS CONNECTORS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 51 KEY PLAYERS PROVIDING CANNULAS
  • TABLE 52 ASEAN NON-DEDICATED ACCESSORIES AND CONSUMABLES MARKET FOR CANNULAS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 53 KEY PLAYERS PROVIDING TUBING AND EXTENSION SETS
  • TABLE 54 ASEAN NON-DEDICATED ACCESSORIES AND CONSUMABLES MARKET FOR TUBING AND EXTENSION SETS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 55 KEY PLAYERS PROVIDING VALVES
  • TABLE 56 ASEAN NON-DEDICATED ACCESSORIES AND CONSUMABLES MARKET FOR VALVES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 57 KEY PLAYERS PROVIDING OTHER NON-DEDICATED ACCESSORIES AND CONSUMABLES
  • TABLE 58 ASEAN OTHER NON-DEDICATED ACCESSORIES AND CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 59 KEY PLAYERS PROVIDING INFUSION PUMP DEVICES
  • TABLE 60 DEVICES: ASEAN INFUSION PUMPS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 61 DEVICES: ASEAN INFUSION PUMPS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 62 KEY PLAYERS PROVIDING VOLUMETRIC INFUSION PUMPS (DEVICES)
  • TABLE 63 ASEAN VOLUMETRIC INFUSION PUMPS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 64 KEY PLAYERS PROVIDING INSULIN INFUSION PUMPS
  • TABLE 65 ASEAN INSULIN INFUSION PUMPS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 66 KEY PLAYERS PROVIDING AMBULATORY INFUSION PUMPS (DEVICES)
  • TABLE 67 ASEAN AMBULATORY INFUSION PUMPS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 68 KEY PLAYERS PROVIDING SYRINGE INFUSION PUMPS (DEVICES)
  • TABLE 69 ASEAN SYRINGE INFUSION PUMPS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 70 KEY PLAYERS PROVIDING ENTERAL INFUSION PUMPS (DEVICES)
  • TABLE 71 ASEAN ENTERAL INFUSION PUMPS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 72 KEY PLAYERS PROVIDING PCA PUMPS
  • TABLE 73 ASEAN PCA PUMPS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 74 KEY PLAYERS PROVIDING IMPLANTABLE INFUSION PUMPS (DEVICES)
  • TABLE 75 ASEAN IMPLANTABLE INFUSION PUMPS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 76 ASEAN INFUSION PUMP DEVICES MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
  • TABLE 77 ASEAN INFUSION PUMP DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 78 KEY PLAYERS PROVIDING TRADITIONAL INFUSION PUMPS
  • TABLE 79 ASEAN TRADITIONAL INFUSION PUMPS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 80 KEY PLAYERS PROVIDING SPECIALTY INFUSION PUMPS
  • TABLE 81 ASEAN SPECIALTY INFUSION PUMPS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 82 ASEAN INFUSION PUMP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 83 ASEAN INFUSION PUMP DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 84 KEY PLAYERS PROVIDING STATIONARY INFUSION PUMPS
  • TABLE 85 ASEAN STATIONARY INFUSION PUMPS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 86 KEY PLAYERS PROVIDING PORTABLE INFUSION PUMPS
  • TABLE 87 ASEAN PORTABLE INFUSION PUMPS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 88 ASEAN INFUSION PUMPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 89 KEY PLAYERS PROVIDING INFUSION PUMPS FOR CHEMOTHERAPY/ONCOLOGY APPLICATIONS
  • TABLE 90 ASEAN INFUSION PUMPS MARKET FOR CHEMOTHERAPY/ONCOLOGY APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 91 KEY PLAYERS PROVIDING INFUSION PUMPS FOR DIABETES MANAGEMENT
  • TABLE 92 ASEAN INFUSION PUMPS MARKET FOR DIABETES MANAGEMENT APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 93 DISEASES AND DISORDERS OF DIGESTIVE SYSTEM
  • TABLE 94 KEY PLAYERS PROVIDING INFUSION PUMPS FOR GASTROENTEROLOGY APPLICATIONS
  • TABLE 95 ASEAN INFUSION PUMPS MARKET FOR GASTROENTEROLOGY APPLICATIONS,BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 96 KEY PLAYERS PROVIDING INFUSION PUMPS FOR ANALGESIA/PAIN MANAGEMENT APPLICATIONS
  • TABLE 97 ASEAN INFUSION PUMPS MARKET FOR ANALGESIA/PAIN MANAGEMENT APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 98 KEY PLAYERS PROVIDING INFUSION PUMPS FOR PEDIATRICS/NEONATOLOGY APPLICATIONS
  • TABLE 99 ASEAN INFUSION PUMPS MARKET FOR PEDIATRIC/NEONATOLOGY APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 100 KEY PLAYERS PROVIDING INFUSION PUMPS FOR HEMATOLOGY APPLICATIONS
  • TABLE 101 ASEAN INFUSION PUMPS MARKET FOR HEMATOLOGY APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 102 KEY PLAYERS PROVIDING INFUSION PUMP FOR OTHER APPLICATIONS
  • TABLE 103 ASEAN INFUSION PUMPS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 104 ASEAN INFUSION PUMPS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 105 ASEAN INFUSION PUMPS MARKET FOR HOSPITALS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 106 ASEAN INFUSION PUMPS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 107 ASEAN INFUSION PUMPS MARKET FOR AMBULATORY CARE SETTINGS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 108 ASEAN INFUSION PUMPS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES,BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 109 ASEAN INFUSION PUMPS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 110 KEY MACRO INDICATORS FOR PHILIPPINES
  • TABLE 111 PHILIPPINES: INFUSION PUMPS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 112 PHILIPPINES: INFUSION PUMPS MARKET VOLUME ESTIMATES (NUMBER OF UNITS SOLD), 2023–2030 (THOUSAND UNITS)
  • TABLE 113 PHILIPPINES: INFUSION PUMPS MARKET FOR ACCESSORIES & CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 114 PHILIPPINES: ASEAN INFUSION SET FOR PUMP MARKET, 2023–2030 (THOUSAND UNITS)
  • TABLE 115 PHILIPPINES: DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 116 PHILIPPINES: NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 117 PHILIPPINES: INFUSION PUMPS MARKET FOR DEVICES, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 118 PHILIPPINES: INFUSION PUMPS MARKET FOR DEVICES, BY TECHNOLOGY, 2023–2030 (USD MILLION)
  • TABLE 119 PHILIPPINES: INFUSION PUMP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 120 PHILIPPINES: INFUSION PUMPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 121 PHILIPPINES: INFUSION PUMPS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 122 KEY MACRO INDICATORS FOR MALAYSIA
  • TABLE 123 MALAYSIA: INFUSION PUMPS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 124 MALAYSIA: INFUSION PUMPS MARKET VOLUME ESTIMATES (NUMBER OF UNITS SOLD), 2023–2030 (THOUSAND UNITS)
  • TABLE 125 MALAYSIA: INFUSION PUMPS MARKET FOR ACCESSORIES & CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 126 MALAYSIA: ASEAN INFUSION SET FOR PUMP MARKET, 2023–2030 (THOUSAND UNITS)
  • TABLE 127 MALAYSIA: DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 128 MALAYSIA: NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 129 MALAYSIA: INFUSION PUMPS MARKET FOR DEVICES, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 130 MALAYSIA: INFUSION PUMPS MARKET FOR DEVICES, BY TECHNOLOGY, 2023–2030 (USD MILLION)
  • TABLE 131 MALAYSIA: INFUSION PUMPS MARKET FOR DEVICES, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 132 MALAYSIA: INFUSION PUMPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 133 MALAYSIA: INFUSION PUMPS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 134 KEY MACRO INDICATORS FOR VIETNAM
  • TABLE 135 VIETNAM: INFUSION PUMPS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 136 VIETNAM: INFUSION PUMPS MARKET VOLUME ESTIMATES (NUMBER OF UNITS SOLD), 2023–2030 (THOUSAND UNITS)
  • TABLE 137 VIETNAM: INFUSION PUMPS MARKET FOR ACCESSORIES & CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 138 VIETNAM: ASEAN INFUSION SET FOR PUMP MARKET, 2023–2030 (THOUSAND UNITS)
  • TABLE 139 VIETNAM: DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 140 VIETNAM: NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 141 VIETNAM: INFUSION PUMPS MARKET FOR DEVICES, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 142 VIETNAM: INFUSION PUMPS MARKET FOR DEVICES, BY TECHNOLOGY, 2023–2030 (USD MILLION)
  • TABLE 143 VIETNAM: INFUSION PUMPS MARKET FOR DEVICES, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 144 VIETNAM: INFUSION PUMPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 145 VIETNAM: INFUSION PUMPS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 146 KEY MACRO INDICATORS FOR SINGAPORE
  • TABLE 147 SINGAPORE: INFUSION PUMPS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 148 SINGAPORE: INFUSION PUMPS MARKET VOLUME ESTIMATES (NUMBER OF UNITS SOLD), 2023–2030 (THOUSAND UNITS)
  • TABLE 149 SINGAPORE: INFUSION PUMPS MARKET FOR ACCESSORIES & CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 150 SINGAPORE: INFUSION SET FOR PUMP MARKET, 2023–2030 (THOUSAND UNITS)
  • TABLE 151 SINGAPORE: DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 152 SINGAPORE: NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 153 SINGAPORE: INFUSION PUMPS MARKET FOR DEVICES, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 154 SINGAPORE: INFUSION PUMPS MARKET FOR DEVICES, BY TECHNOLOGY, 2023–2030 (USD MILLION)
  • TABLE 155 SINGAPORE: INFUSION PUMPS MARKET FOR DEVICES, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 156 SINGAPORE: INFUSION PUMPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 157 SINGAPORE: INFUSION PUMPS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 158 KEY MACRO INDICATORS FOR INDONESIA
  • TABLE 159 INDONESIA: INFUSION PUMPS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 160 INDONESIA: INFUSION PUMPS MARKET VOLUME ESTIMATES (NUMBER OF UNITS SOLD), 2023–2030 (THOUSAND UNITS)
  • TABLE 161 INDONESIA: INFUSION PUMPS MARKET FOR ACCESSORIES & CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 162 INDONESIA: ASEAN INFUSION SET FOR PUMP MARKET, 2023–2030 (THOUSAND UNITS)
  • TABLE 163 INDONESIA: DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 164 INDONESIA: NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 165 INDONESIA: INFUSION PUMPS MARKET FOR DEVICES, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 166 INDONESIA: INFUSION PUMPS MARKET FOR DEVICES, BY TECHNOLOGY, 2023–2030 (USD MILLION)
  • TABLE 167 INDONESIA: INFUSION PUMPS MARKET FOR DEVICES, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 168 INDONESIA: INFUSION PUMPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 169 INDONESIA: INFUSION PUMPS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 170 KEY MACRO INDICATORS FOR THAILAND
  • TABLE 171 THAILAND: INFUSION PUMPS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 172 THAILAND: INFUSION PUMPS MARKET VOLUME ESTIMATES (NUMBER OF UNITS SOLD), 2023–2030 (THOUSAND UNITS)
  • TABLE 173 THAILAND: INFUSION PUMPS MARKET FOR ACCESSORIES & CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 174 THAILAND: ASEAN INFUSION SET FOR PUMP MARKET, 2023–2030 (THOUSAND UNITS)
  • TABLE 175 THAILAND: DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 176 THAILAND: NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 177 THAILAND: INFUSION PUMPS MARKET FOR DEVICES, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 178 THAILAND: INFUSION PUMPS MARKET FOR DEVICES, BY TECHNOLOGY, 2023–2030 (USD MILLION)
  • TABLE 179 THAILAND: INFUSION PUMPS MARKET FOR DEVICES, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 180 THAILAND: INFUSION PUMPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 181 THAILAND: INFUSION PUMPS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 182 SOUTH KOREA: MACROECONOMIC INDICATORS
  • TABLE 183 SOUTH KOREA: INFUSION PUMPS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 184 SOUTH KOREA: INFUSION PUMPS MARKET VOLUME ESTIMATES (NUMBER OF UNITS SOLD), 2023–2030 (THOUSAND UNITS)
  • TABLE 185 SOUTH KOREA: INFUSION PUMPS MARKET FOR ACCESSORIES & CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 186 SOUTH KOREA: ASEAN INFUSION SET FOR PUMP MARKET, 2023–2030 (THOUSAND UNITS)
  • TABLE 187 SOUTH KOREA: DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 188 SOUTH KOREA: NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 189 SOUTH KOREA: INFUSION PUMPS MARKET FOR DEVICES, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 190 SOUTH KOREA: INFUSION PUMPS MARKET FOR DEVICES, BY TECHNOLOGY, 2023–2030 (USD MILLION)
  • TABLE 191 SOUTH KOREA: INFUSION PUMPS MARKET FOR DEVICES, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 192 SOUTH KOREA: INFUSION PUMPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 193 SOUTH KOREA: INFUSION PUMPS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 194 ASEAN INFUSION PUMPS MARKET: OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS, 2022–2025
  • TABLE 195 ASEAN INFUSION PUMPS MARKET: DEGREE OF COMPETITION
  • TABLE 196 ASEAN INFUSION PUMPS MARKET: PRODUCT FOOTPRINT
  • TABLE 197 ASEAN INFUSION PUMPS MARKET: APPLICATION FOOTPRINT
  • TABLE 198 ASEAN INFUSION PUMPS MARKET: END USER FOOTPRINT
  • TABLE 199 ASEAN INFUSION PUMPS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 200 ASEAN INFUSION PUMPS MARKET: COMPETITIVE BENCHMARKING OFKEY STARTUPS/SMES
  • TABLE 201 ASEAN INFUSION PUMPS MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–MAY 2025
  • TABLE 202 ASEAN INFUSION PUMPS MARKET: DEALS, JANUARY 2022–MAY 2025
  • TABLE 203 ASEAN INFUSION PUMPS MARKET: EXPANSIONS, JANUARY 2022–MAY 2025
  • TABLE 204 ASEAN INFUSION PUMPS MARKET: OTHER DEVELOPMENTS, JANUARY 2022–MARCH 2025
  • TABLE 205 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW
  • TABLE 206 BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED
  • TABLE 207 BECTON, DICKINSON AND COMPANY: PRODUCT LAUNCHES & APPROVALS
  • TABLE 208 BECTON, DICKINSON AND COMPANY: DEALS
  • TABLE 209 BECTON, DICKINSON AND COMPANY: EXPANSIONS
  • TABLE 210 BECTON, DICKINSON AND COMPANY: OTHER DEVELOPMENTS
  • TABLE 211 B. BRAUN MELSUNGEN AG: COMPANY OVERVIEW
  • TABLE 212 B. BRAUN MELSUNGEN AG: PRODUCTS OFFERED
  • TABLE 213 B. BRAUN MELSUNGEN AG: PRODUCT LAUNCHES & APPROVALS
  • TABLE 214 B. BRAUN MELSUNGEN AG: DEALS
  • TABLE 215 B. BRAUN MELSUNGEN AG: OTHER DEVELOPMENTS
  • TABLE 216 BAXTER INTERNATIONAL INC.: COMPANY OVERVIEW
  • TABLE 217 BAXTER INTERNATIONAL INC.: PRODUCTS OFFERED
  • TABLE 218 BAXTER INTERNATIONAL INC.: PRODUCT LAUNCHES & APPROVALS
  • TABLE 219 BAXTER INTERNATIONAL INC.: DEALS
  • TABLE 220 BAXTER INTERNATIONAL INC.: OTHER DEVELOPMENTS
  • TABLE 221 FRESENIUS KABI: COMPANY OVERVIEW
  • TABLE 222 FRESENIUS KABI: PRODUCTS OFFERED
  • TABLE 223 FRESENIUS KABI: PRODUCT LAUNCHES & APPROVALS
  • TABLE 224 FRESENIUS KABI: DEALS
  • TABLE 225 FRESENIUS KABI: OTHERS, JANUARY 2022-APRIL 202
  • TABLE 226 MEDTRONIC PLC: COMPANY OVERVIEW
  • TABLE 227 MEDTRONIC PLC: PRODUCTS OFFERED
  • TABLE 228 MEDTRONIC PLC: PRODUCT LAUNCHES & APPROVALS
  • TABLE 229 MEDTRONIC PLC: DEALS
  • TABLE 230 TERUMO CORPORATION: COMPANY OVERVIEW
  • TABLE 231 TERUMO CORPORATION: PRODUCTS OFFERED
  • TABLE 232 TERUMO CORPORATION: PRODUCT LAUNCHES & APPROVALS
  • TABLE 233 TERUMO CORPORATION: EXPANSIONS
  • TABLE 234 TERUMO CORPORATION: DEALS
  • TABLE 235 ICU MEDICAL, INC.: COMPANY OVERVIEW
  • TABLE 236 ICU MEDICAL, INC.: PRODUCTS OFFERED
  • TABLE 237 ICU MEDICAL, INC.: PRODUCT LAUNCHES & APPROVALS
  • TABLE 238 ICU MEDICAL, INC.: DEALS
  • TABLE 239 ICU MEDICAL, INC.: OTHER DEVELOPMENTS
  • TABLE 240 AVANOS MEDICAL, INC.: COMPANY OVERVIEW
  • TABLE 241 AVANOS MEDICAL, INC.: PRODUCTS OFFERED
  • TABLE 242 NIPRO CORPORATION: COMPANY OVERVIEW
  • TABLE 243 NIPRO CORPORATION: PRODUCTS OFFERED
  • TABLE 244 NIPRO CORPORATION: EXPANSIONS
  • TABLE 245 JMS CO., LTD.: COMPANY OVERVIEW
  • TABLE 246 JMS CO., LTD.: PRODUCTS OFFERED
  • TABLE 247 CARDINAL HEALTH, INC.: COMPANY OVERVIEW
  • TABLE 248 CARDINAL HEALTH, INC.: PRODUCTS OFFERED
  • TABLE 249 ROCHE DIAGNOSTICS: COMPANY OVERVIEW
  • TABLE 250 ROCHE DIAGNOSTICS: PRODUCTS OFFERED
  • TABLE 251 ROCHE DIAGNOSTICS: EXPANSIONS
  • TABLE 252 ABBOTT LABORATORIES: COMPANY OVERVIEW
  • TABLE 253 ABBOTT LABORATORIES: PRODUCTS OFFERED
  • TABLE 254 DANAHER CORPORATION: COMPANY OVERVIEW
  • TABLE 255 DANAHER CORPORATION: PRODUCTS OFFERED
  • TABLE 256 YPSOMED HOLDING AG: COMPANY OVERVIEW
  • TABLE 257 YPSOMED HOLDING AG: PRODUCTS OFFERED
LIST OF FIGURES
 
  • FIGURE 1 ASEAN INFUSION PUMPS MARKET SEGMENTATION
  • FIGURE 2 RESEARCH DESIGN
  • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER TYPE, DESIGNATION, AND REGION
  • FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2024)
  • FIGURE 6 ASEAN INFUSION PUMPS MARKET: SUPPLY-SIDE ANALYSIS
  • FIGURE 7 TOP-DOWN APPROACH
  • FIGURE 8 ASEAN INFUSION PUMPS MARKET: CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2025–2030)
  • FIGURE 9 ASEAN INFUSION PUMPS MARKET: CAGR PROJECTIONS FROM SUPPLY-SIDE ANALYSIS (2025–2030)
  • FIGURE 10 DATA TRIANGULATION METHODOLOGY
  • FIGURE 11 ASEAN INFUSION PUMPS MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION)
  • FIGURE 12 ASEAN INFUSION PUMPS MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
  • FIGURE 13 ASEAN INFUSION PUMPS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
  • FIGURE 14 ASEAN INFUSION PUMPS MARKET: GEOGRAPHIC SNAPSHOT
  • FIGURE 15 RISING NUMBER OF CHRONIC DISORDERS TO DRIVE MARKET
  • FIGURE 16 ACCESSORIES AND CONSUMABLES SEGMENT AND SOUTH KOREA ACCOUNTED FOR LARGEST MARKET SHARES IN 2024
  • FIGURE 17 SOUTH KOREA TO LEAD MARKET THROUGHOUT FORECAST PERIOD
  • FIGURE 18 SOUTH KOREA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 19 SOUTH KOREA TO LEAD MARKET DURING FORECAST PERIOD
  • FIGURE 20 ASEAN INFUSION PUMPS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 21 ASIAN CANCER INCIDENCE, 2020–2040
  • FIGURE 22 DIABETES PREVALENCE IN PEOPLE AGED 65–99 YEARS, BY REGION (2024 VS. 2050)
  • FIGURE 23 ASEAN INFUSION PUMPS MARKET: PORTER’S FIVE FORCES ANALYSIS
  • FIGURE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS
  • FIGURE 25 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS
  • FIGURE 26 ASEAN INFUSION PUMPS MARKET: PATENTS APPLIED AND GRANTED, JANUARY 2014–MAY 2025
  • FIGURE 27 TOP PATENT APPLICANT COUNTRIES/REGIONS FOR INFUSION PUMPS,JANUARY 2014–MAY 2025
  • FIGURE 28 AVERAGE SELLING PRICE TREND FOR VOLUMETRIC INFUSION PUMPS, INSULIN PUMPS, AND SYRINGE INFUSION PUMPS, BY KEY PLAYER, 2024
  • FIGURE 29 AI USE CASES
  • FIGURE 30 ASEAN INFUSION PUMPS MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 31 ASEAN INFUSION PUMPS MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 32 ASEAN INFUSION PUMPS MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 33 ASEAN INFUSION PUMP MARKET: ADJACENT MARKETS
  • FIGURE 34 REVENUE SHIFTS AND NEW REVENUE POCKETS FOR ASEAN INFUSION PUMPS MARKET
  • FIGURE 35 ASEAN INFUSION PUMPS MARKET SNAPSHOT
  • FIGURE 36 ASEAN INFUSION PUMPS MARKET: REVENUE ANALYSIS OF TOP FIVE PLAYERS, 2020–2024
  • FIGURE 37 SHARE ANALYSIS OF ASEAN INFUSION PUMPS MARKET, 2024
  • FIGURE 38 ASEAN INFUSION PUMPS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS, 2024
  • FIGURE 39 ASEAN INFUSION PUMPS MARKET: COMPANY FOOTPRINT
  • FIGURE 40 ASEAN INFUSION PUMPS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
  • FIGURE 41 R&D EXPENDITURE OF KEY PLAYERS IN ASEAN INFUSION PUMPS MARKET, 2022−2024
  • FIGURE 42 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 43 EV/EBITDA OF KEY VENDORS
  • FIGURE 44 ASEAN INFUSION PUMPS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 45 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2024)
  • FIGURE 46 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2024)
  • FIGURE 47 BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT (2024)
  • FIGURE 48 FRESENIUS KABI: COMPANY SNAPSHOT (2024)
  • FIGURE 49 MEDTRONIC PLC: COMPANY SNAPSHOT (2024)
  • FIGURE 50 TERUMO CORPORATION: COMPANY SNAPSHOT (2024)
  • FIGURE 51 ICU MEDICAL, INC.: COMPANY SNAPSHOT (2024)
  • FIGURE 52 AVANOS MEDICAL, INC.: COMPANY SNAPSHOT (2024)
  • FIGURE 53 NIPRO CORPORATION: COMPANY SNAPSHOT (2024)
  • FIGURE 54 JMS CO., LTD.: COMPANY SNAPSHOT (2024)
  • FIGURE 55 CARDINAL HEALTH, INC.: COMPANY SNAPSHOT (2024)
  • FIGURE 56 ROCHE DIAGNOSTICS.: COMPANY SNAPSHOT (2024)
  • FIGURE 57 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2024)
  • FIGURE 58 DANAHER CORPORATION: COMPANY SNAPSHOT (2024)
  • FIGURE 59 YPSOMED HOLDING AG: COMPANY SNAPSHOT (2024)

 

The study involved four major activities to estimate the current size of the Association of Southeast Asian Nations (ASEAN) infusion pump market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.

Secondary Research

In the secondary research process, various sources were utilized to identify and gather information for the study of the ASEAN infusion pump market. These sources included company annual reports, press releases, investor presentations, white papers, certified publications, and articles by recognized authors. Reputable websites, regulatory bodies, and databases such as D&B Hoovers, Bloomberg Business, and Factiva are consulted for this study.

This research aimed to gather crucial information about the leading companies in the industry, market classification, and segmentation based on industry trends down to the most detailed levels, including geographic markets. Additionally, key developments related to the market are also being focused. Through this secondary research, a database of key industry leaders was created.

Primary Research

Extensive primary research was conducted after gathering information about the ASEAN infusion pump market through secondary research. Several primary interviews were held with market experts from both the demand and supply sides across major regions, including North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. Data was collected through questionnaires, emails, and telephone interviews. The primary sources from the supply side included various industry experts, such as CEOs, VPs, Directors of business development, marketing, product development/innovation teams, and other key executives from manufacturers and distributors operating in the ASEAN infusion pump market and key opinion leaders.

Primary interviews were conducted to gather valuable insights, including market statistics, revenue data from products and services, market breakdowns, market size estimations, market forecasting, and data triangulation. This primary research also provided an understanding of various trends related to technologies, applications, industry verticals, and regions. Stakeholders, including customers and end users, were interviewed to gain the buyers' perspective on suppliers, the products themselves, their current usage, and the future outlook of their businesses. This information is crucial as it impacts the overall market dynamics.

The following is a breakdown of the primary respondents:

ASEAN Infusion Pump Market

Note 1: C-level executives include CEOs, COOs, CTOs, and VPs.

Note 2: Others include sales, marketing, and product managers.

Note 3: Companies are classified into tiers based on their total revenue. As of 2024: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, Tier 3 = < USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The research methodology used to estimate the size of the ASEAN infusion pump market includes the following details.

The market sizing was undertaken from the global side.

Country-level Analysis: The size of the ASEAN infusion pump market was obtained from the annual presentations of leading players and secondary data available in the public domain. Shares of products in the overall market were obtained from secondary data and validated by primary participants to arrive at the total ASEAN infusion pump market. Primary participants further validated the numbers.

Geographic Market Assessment (By Country): The geographic assessment was done using the following approaches:

Approach 1: Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends

Approach 2: Geographic adoption trends for individual product segments by end users and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews)

At each point, the assumptions and approaches were validated by industry experts who were contacted during primary research. Considering the limitations of data available from secondary research, revenue estimates for individual companies (for the overall ASEAN infusion pump market and geographic market assessment) were ascertained based on a detailed analysis of their respective product offerings, geographic reach/strength (direct or through distributors or suppliers), and the shares of the leading players in a particular country.

ASEAN infusion pump Market Size: Bottom-up and Top-down Approach

ASEAN Infusion Pump Market

Data Triangulation

The market was split into several segments and subsegments after arriving at the overall market size—using the market size estimation processes. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment. The data was triangulated by studying various factors and trends from both the demand and supply sides in the ASEAN infusion pump market.

Market Definition

The ASEAN infusion pump market encompasses the medical device industry sector, which is dedicated to the manufacturing, distribution, and application of infusion pumps within the ASEAN member states. Infusion pumps are sophisticated medical devices engineered to administer precise volumes of fluids—such as nutrients, pharmaceuticals, or blood products—into a patient's circulatory system over predetermined intervals. Their critical role extends across various clinical environments, including acute care hospitals and outpatient facilities, and with the rise of home healthcare, there is an increasing number of domestic settings. These devices are essential for ensuring accurate drug delivery and managing fluid therapy in diverse patient populations.

Stakeholders

  • Product distributors and channel partners
  • Suppliers and distributors of ASEAN infusion pumps
  • Medical Device Manufacturers
  • Healthcare Providers
  • Healthcare services providers (Hospitals and public & private clinics)
  • Government associations
  • Market research and consulting firms
  • Venture capitalists and investors
  • Patients and End Users
  • Research Institutions and Academia

Report Objectives

  • To define, describe, and forecast the ASEAN infusion pump market based on product, application, end user, and region
  • To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
  • To strategically analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall ASEAN infusion pump market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To estimate the market size and growth potential of the infusion pump market in the Asia Pacific region
  • To profile the key players operating in the ASEAN infusion pump market and comprehensively analyze their revenue shares, core competencies2, and market shares
  • To track and analyze competitive developments such as geographical expansions, acquisitions, collaborations, product launches, agreements, collaborations, and partnerships in the ASEAN infusion pump market
  • To benchmark players in the market using the proprietary “Competitive Leadership Mapping” framework, which analyzes market players on various parameters within the board categories of business strategy and product offering

 

Previous Versions of this Report

APAC Infusion Pumps Market by Product (Accessories (Dedicated, Non-dedicated), Devices (Volumetric, Insulin, Syringe, Ambulatory)), Technology (Traditional, Specialty), Application (Cancer, Diabetes), End User (Hospital, Home Care) & Region - Global Forecasts to 2027

Report Code MD 8084
Published in Apr, 2022, By MarketsandMarkets™
"Our USP is "providing game-changing business opportunities reports with free customization" - so please feel free to provide us with your specific areas of interest / business challenges in much greater detail !!"

We appreciate your interest in this report. Once you fill out the form, you'll be immediately directed to an exclusive solution tailored to your needs. This high-value offering can help boost your revenue by 30% - a must-see opportunity for anyone looking to maximize growth.

By clicking the "Submit" button, you are agreeing to the Terms of Use and Privacy Policy.

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in ASEAN Infusion Pump Market

User

Apr, 2022

I would like to know more about the Infusion Pumps market in Australia. What will the market look like in this region and which major companies are operating here?.

+1-888600-6441

Corporate Office Hours

+1-888600-6441

US/Can Toll Free

+44-800-368-9399

UK Office Hours

©2025 Marketsandmarkets Research Private Ltd. All Rights Reserved.

DMCA.com Protection Status